Great analysis, thank you for taking the time.
If Japan has a lower bar to pass a product to market and MSB allready has a pathway through dealings with JCR.
What is preventing them from launching CLBP and CHF in Japan and making some money to support the time it takes to complete FDA approval in the US?
Great analysis, thank you for taking the time. If Japan has a...
Add to My Watchlist
What is My Watchlist?
